Search

everythinglearnresearchcommunity

for

Search:↓

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Giving dihydrotachysterol to mother rats caused skin hardening and bone issues in their babies through milk.

Hair changes can indicate systemic diseases or medication effects.

NEMO syndrome and systemic lupus erythematosus are linked in a new disease association.

EPDS and MS might share an immune-related cause.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

COVID-19 vaccination may trigger lupus in some people.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

A woman with lupus and severe nerve damage improved with specific treatments.

Recognizing CVG can help diagnose systemic amyloidosis early.

ANA-negative lupus nephritis can be diagnosed and treated effectively with a comprehensive approach.

Dietary lipids affect inflammation and are crucial for normal cell function and immune health.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.